Lease Commitments:	12 Months Ended
Feb. 28, 2025
Lease Commitments:
Lease Commitments:	4. Lease Commitments: Dr. Burzynski leases certain equipment used in the clinical trials under leases originally maturing in one to four years. These costs are included in general and administrative expenses and also included in contributed capital by Dr. Burzynski. Rent expense incurred under these leases was approximately $73,600 and $71,500 for the years ended February 28, 2025 and February 29, 2024, respectively. As explained in Note 2, Dr. Burzynski owns the facility used by the Company to perform research and produce its drug products. There is currently no lease agreement; however, the facility’s costs are included in the accompanying financial statements as rental expense. The rental expense is derived from not only utilities and expenses normally incurred by a tenant but also mortgage interest, insurance, property taxes and building depreciation. Rent expense totaled $345,544 and $295,456 for February 28, 2025 and February 29, 2024, respectively.

Lease Commitments:

12 Months Ended

Feb. 28, 2025

4. Lease Commitments:

Dr. Burzynski leases certain equipment used in the clinical trials under leases originally maturing in one to four years. These costs are included in general and administrative expenses and also included in contributed capital by Dr. Burzynski. Rent expense incurred under these leases was approximately $73,600 and $71,500 for the years ended February 28, 2025 and February 29, 2024, respectively.

As explained in Note 2, Dr. Burzynski owns the facility used by the Company to perform research and produce its drug products. There is currently no lease agreement; however, the facility’s costs are included in the accompanying financial statements as rental expense. The rental expense is derived from not only utilities and expenses normally incurred by a tenant but also mortgage interest, insurance, property taxes and building depreciation. Rent expense totaled $345,544 and $295,456 for February 28, 2025 and February 29, 2024, respectively.